Abstract
No public abstract is available from the verified source records.
Ngoc The Nguyen, Quoc Khanh Nguyen, Khanh Linh Ly, Tan Phuoc Ton, Thong Hoang Tran, Trung Dinh Nguyen, Van Toan Nguyen, Huy Q. Ly
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Cisplatin: the first metal based anticancer drug
10.1016/j.bioorg.2019.102925 · 2019
Platinum-based chemotherapy: trends in organic nanodelivery systems
10.1039/d4nr01483a · 2024
Cisplatin in cancer therapy: molecular mechanisms of action
10.1016/j.ejphar.2014.07.025 · 2014
Advances in understanding cisplatin-induced toxicity: molecular mechanisms and protective strategies
10.1016/j.ejps.2024.106939 · 2024
Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology
10.1021/cr040704h · 2006
Quantification of cisplatin encapsulated in nanomedicine: an overview
10.3390/bios15050293 · 2025
Strategies for sustained release of heparin: a review
10.1016/j.carbpol.2022.119793 · 2022
Tumor microenvironment-responsive PEGylated heparin-pyropheophorbide-a nanoconjugates for photodynamic therapy
10.1016/j.carbpol.2020.117490 · 2021
Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles
10.1021/nn202410f · 2011
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
10.1126/sciadv.adz7615
10.1126/sciadv.adz7615
Dumbbell-like Au−Fe3O4 nanoparticles for target-specific platin delivery
10.1021/ja900790v · 2009
Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery
10.1016/j.matdes.2019.108187 · 2019
Synergic activity against MCF-7 breast cancer cell growth of nanocurcumin-encapsulated and cisplatin-complexed nanogels
10.3390/molecules23123347 · 2018
Inhibition of cancer-associated thrombosis with redox-sensitive paclitaxel/heparin-deoxycholic acid nanoparticles
10.1016/j.colcom.2020.100345 · 2021
Heparin-coated colloidal mesoporous silica nanoparticles efficiently bind to antithrombin as an anticoagulant drug-delivery system
10.1002/chem.201102926 · 2012
Optimization of the poloxamer 407-conjugated gelatin to synthesize pH-sensitive nanocarriers for controlled paclitaxel delivery
10.1007/s10965-024-04248-1 · 2025
Poloxamer hydrogels for biomedical applications
10.3390/pharmaceutics11120671 · 2019
Self-assembled nanogel of pluronic-conjugated heparin as a versatile drug nanocarrier
10.1007/s13233-011-0214-4 · 2011
Heparin-pluronic F127 nanogel with optimal component ratio for drug delivery applications
10.54939/1859-1043.j.mst.88.2023.58-65 · 2023
Aquated cisplatin and heparin-pluronic nanocomplexes exhibiting sustainable release of active platinum compound and NCI-H460 lung cancer cell antiproliferation
10.1080/09205063.2016.1154239 · 2016
Application of pluronics for enhancing aqueous solubility of lipophilic microtubule destabilizing compounds on the sea urchin embryo model
10.3390/ijms241914695 · 2023
Amphiphile-drug interplay: enhanced solubility and drug-tailored self-assembly for delivery applications
2026
Novel amphiphilic heparin-pluronic P123 copolymers exhibiting a great potential for cisplatin delivery
10.1007/s10853-018-2569-9 · 2018
Unresolved referenced work
Kept as external metadata until matched
Development and evaluation of folate-gelatin-poloxamer P407 copolymer nanogels for enhanced co-delivery of paclitaxel and curcumin in breast cancer therapy
2024
A study of liposomal formulations to improve the delivery of aquated cisplatin to a multidrug resistant tumor
10.1007/s11095-015-1702-6 · 2015
A novel information criterion to elucidate a drug delivery mechanism from poly (acrylamide-co-2-hydroxyethyl methacrylate) reinforced with hydroxyapatite composite
10.1016/j.polymer.2018.10.068 · 2018
Biopolymeric nanocapsules exploiting the synergistic effects of methotrexate and curcumin co-delivery via oral or local administration for breast cancer therapy
10.1016/j.xphs.2026.104288 · 2026
Gelatinized-polyoxyethylene (100) stearyl ether nanoformulation for enhancing distribution, bioavailability and stability of curcumin in cancer therapy
10.1007/s13233-025-00421-7 · 2025
1H and (15)N NMR analyses on heparin, heparan sulfates and related monosaccharides concerning the chemical exchange regime of the N-Sulfo-Glucosamine sulfamate proton
10.3390/ph9030058 · 2016
Unresolved referenced work
2024
Structural modification of gelatin-based conjugates for hydrophobic drug delivery: superior efficacy of poloxamer 403 grafting in curcumin and paclitaxel Co-Loading
10.1007/s10876-026-03021-2 · 2026
Lipophilic effect of various pluronic-grafted gelatin copolymers on the Quercetin delivery efficiency in these self-assembly nanogels
10.1007/s10965-020-02216-z · 2020
Heparin-tagged PLA-PEG copolymer-encapsulated biochanin A-Loaded (Mg/Al) LDH nanoparticles recommended for non-thrombogenic and anti-proliferative stent coating
10.3390/ijms22115433 · 2021
Investigation of the properties of chitosan–Pluronic based nanogel drug delivery systems utilizing various pluronic types
10.1002/pen.26923 · 2024
pH sensitive and controlled release system based on cellulose nanofibers-poly vinyl alcohol hydrogels for cisplatin delivery
10.1007/s12221-017-6958-5 · 2017
Core–shell polymer nanoparticles for prevention of GSH drug detoxification and cisplatin delivery to breast cancer cells
10.1039/c5nr04963f · 2015
Size-tunable strategies for a tumor targeted drug delivery system
10.1021/acscentsci.9b01139 · 2020
Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems
10.3390/pharmaceutics10020057 · 2018
Positive surface charge enhances selective cellular uptake and anticancer efficacy of selenium nanoparticles
10.1021/ic301050v · 2012
In vitro hemolysis: guidance for the pharmaceutical scientist
10.1002/jps.20627 · doi-reference
Molecular and functional interactions between cisplatin and nicotinamide: a combined computational, spectroscopic, and biological study
10.3390/ijms27114989 · doi-reference
Drug transport mechanisms and in vitro release kinetics of vancomycin encapsulated chitosan-alginate polyelectrolyte microparticles as a controlled drug delivery system
10.1016/j.ejps.2017.12.012 · doi-reference
Calculation of predominant drug release mechanism using peppas-sahlin model, Part-I (substitution method): a linear regression approach
10.5958/2231-5713.2016.00033.7 · doi-reference
A simple equation for the description of solute release. III. Coupling of diffusion and relaxation
10.1016/0378-5173(89)90306-2 · doi-reference
Synthesis and characterization of carboxylic acid conjugated, hydrophobically derivatized, hyperbranched polyglycerols as nanoparticulate drug carriers for cisplatin
10.1021/bm101080p · doi-reference
Use of half-generation PAMAM dendrimers (G0.5-G3.5) with carboxylate end-groups to improve the DACHPtCl(2) and 5-FU efficacy as anticancer drugs
10.3390/molecules26102924 · doi-reference
Anionic linear-globular dendrimer-cis-platinum (II) conjugates promote cytotoxicity in vitro against different cancer cell lines
10.2147/ijn.s8595 · doi-reference
Co-Delivery of hesperetin and cisplatin via hyaluronic acid-modified liposome for targeted inhibition of aggression and metastasis of triple-negative breast cancer
10.1021/acsami.3c03233 · doi-reference
Cisplatin and doxorubicin dual-loaded mesoporous silica nanoparticles for controlled drug delivery
10.1039/c6ra17213j · doi-reference
Beyond chemotherapeutics: cisplatin as a temporary buckle to fabricate drug-loaded nanogels
10.1039/c6cc08230k · doi-reference
Evaluation of anionic half generation 3.5–6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin
10.1016/j.jinorgbio.2011.05.017 · doi-reference
Cisplatin complexes with phosphatidylserine in membranes
10.1021/bi9703047 · doi-reference
Differentiation of endothelial progenitor cells into endothelial cells by heparin-modified supramolecular pluronic nanogels encapsulating bFGF and complexed with VEGF165 genes
10.1016/j.biomaterials.2014.02.038 · doi-reference